Ultrasound Assessment of Diaphragmatic Function in Infants With BPD - Trial NCT04941963
Access comprehensive clinical trial information for NCT04941963 through Pure Global AI's free database. This phase not specified trial is sponsored by Mount Sinai Hospital, Canada and is currently Recruiting. The study focuses on Bronchopulmonary Dysplasia. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Mount Sinai Hospital, Canada
Timeline & Enrollment
N/A
Nov 26, 2019
Dec 15, 2021
Primary Outcome
Evaluation of the diaphragmatic Thickness fraction and diaphragmatic excursion in neonates with bronchopulmonary dysplasia
Summary
Extremely preterm infants have high and prolonged exposure to positive pressure ventilation,
 which contributes to acute lung injury and the development of bronchopulmonary dysplasia
 (BPD). Despite the risk of diaphragmatic dysfunction in infants with BPD, the effect of
 prolonged ventilator support on the diaphragmatic function of preterm infants has not been
 well characterized.
 
 Hence, we aim to characterize the diaphragmatic function of very preterm neonates with BPD
 who are corrected to ≥ 36 weeks using bedside ultrasound in comparison to healthy newborns
 born at ≥ 36 weeks gestation.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04941963
Non-Device Trial